Bullous fixed drug eruption due to erlotinib: A rare case report

Abstract

Fixed Drug Eruption is one of the most common cutaneous adverse drug reactions, of which the bullous variant is a more severe form. Epidermal growth factor (EGFR) inhibitors are one of the prime chemotherapeutic agents used recently in various malignancies. Most of the side effects of EGFR inhibitors are not severe and subside by decreasing the drug dosage. There is no case report of bullous fixed drug eruption caused by EGFR inhibitors; herein, we report a rare case of bullous fixed drug eruption triggered by erlotinib, an EGFR inhibitor.

Keywords

• bullous fixed drug eruption
• erlotinib
• fixed drug eruption